OTC/supplement combos
This article was originally published in The Tan Sheet
Executive Summary
DSHEA does not prohibit marketing OTC/dietary supplement combinations, CHPA says in a Nov. 29 letter to FDA. "If Congress had intended to outlaw combinations of dietary supplements and OTC drugs, it could have done so," CHPA says. Association also notes precedents allow cosmetic/drugs to make both cosmetic and drug claims, and that an April agreement between CFSAN and CDER "effectively recognized the existence of combination products." Letter follows B.F. Ascher and Omni Nutraceuticals' responses to FDA warning letters concerning their Melagesic PM and Inholtra products, respectively (1"The Tan Sheet" Nov. 12, p. 8)...
You may also be interested in...
Supplement/OTC Combos Have Precedents In Other Categories, Firms State
Prior sale of combination products such as drug/ devices or drug/biologics set a precedent for selling dietary supplement/OTC combination products, B.F. Ascher and Omni Nutraceuticals maintain in separate letters sent to FDA Nov. 6
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.